| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 300 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| AMERISERV TRUST & FINANCIAL SVC | 2014-01 | PURCHASE | 2014-12 | 25,336 | 25,810 | -474 | ||||
| AMERISERV TRUST & FINANCIAL SVC | 2013-01 | PURCHASE | 2014-12 | 82,097 | 72,620 | 9,477 | ||||
| GOLDMAN SACHS | 2013-01 | PURCHASE | 2014-12 | 21,415 | 21,415 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| DODGE & COX BALANCED FUND | 35,066 | 34,761 |
| EATON VANCE FLOATING RATE ADV I | 55,511 | 53,591 |
| LOOMIS SAYLES BOND FUND | 32,646 | 31,935 |
| NATIXIS LOOMIS SAYLES STRAT INC | 31,146 | 32,363 |
| OPPENHEIMER SR FLOATING RATE I | 55,520 | 53,602 |
| T ROWE PRICE CAPITAL APPRECIATION | 18,785 | 20,943 |
| TEMPLETON GLOBAL BOND FUND - ADV | 22,438 | 21,470 |
| VANGUARD BALANCED INDEX FD ADM | 17,972 | 21,978 |
| VANGUARD WELLINGTON FUND - ADM | 22,994 | 26,680 |
| IVY SCIENCE & TECH FUND - I | 1,657 | 2,080 |
| JOHN HANCOCK FDS III DISC VAL MCP I | 1,609 | 2,203 |
| LEGG MASON OPPTY TRUST - IN | 2,553 | 4,375 |
| PRIMECAP ODYSSEY AGGRESSIVE GROWTH | 2,979 | 3,989 |
| PRIMECAP ODYSSEY GROWTH | 1,332 | 1,271 |
| PRINCIPAL MIDCAP FUND | 1,745 | 2,446 |
| RYDEX S&P 500 2X STRATEGY - H | 37,364 | 49,301 |
| T ROWE PRICE FINANCIAL SVCS | 3,245 | 4,433 |
| T ROWE PRICE HEALTH SCIENCES | 3,677 | 6,543 |
| VANGUARD INSTITUTIONAL INDEX - INST | 87,574 | 127,096 |
| VANGUARD S&P 500 ETF | 10,222 | 14,507 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ALTRIA GROUP | 2,490 | 3,498 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| MISCELLANEOUS INCOME | 1,655 | 1,655 |